The first therapy that uses gene-editing is to be offered on the NHS in a “revolutionary breakthrough” for patients. It will ...

It will be used as a potential cure for the blood disorder beta thalassaemia. Stem cells which make blood will be extracted, reprogrammed to correct the condition and returned to the patient's body.

Vertex and CRISPR Therapeutics have won the backing of NICE for their gene-editing therapy Casgevy as a treatment for the blood disorder beta thalassaemia, a few months after turning it down for ...

The health system has been decimated. Although violence has fallen, emergency funding is still well short of needs. Sharmila ...

“The war we’re in right now is much harder,” said Arab, who heads the Iranian Thalassaemia Society, which represent those with the blood disorder. “Innocent people are dying, not because ...

The girl was enrolled in a KKH programme called Bridges, or Bringing Research Innovations for the Diagnosis of Genetic ...

when a haematopoietic stem cell transplant (a blood and marrow transplant) is suitable, but a human leukocyte antigen-matched related haematopoietic stem cell donor is not available. More evidence on ...

Work at the Midlands Metropolitan University Hospital in Smethwick is nearly complete, with its doors set to open on Sunday, ...

Next review: More evidence on exagamglogene autotemcel is being collected. After this, NICE will decide whether to recommend it for use in the NHS and update the guidance. It will be available with ...

The Midland Metropolitan University Hospital, which is set to open on October 6, will provide healthcare for people in the ...